These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12941781)

  • 21. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.
    López-Canales JS; López-Sanchez P; Perez-Alvarez VM; Wens-Flores I; Polanco AC; Castillo-Henkel E; Castillo-Henkel C
    Braz J Med Biol Res; 2011 May; 44(5):438-44. PubMed ID: 21445535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corpus cavernosum dysfunction in diabetic rats: effects of combined alpha-lipoic acid and gamma-linolenic acid treatment.
    Keegan A; Cotter MA; Cameron NE
    Diabetes Metab Res Rev; 2001; 17(5):380-6. PubMed ID: 11747143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.
    Yousif MH; Kehinde EO; Benter IF
    Pharmacol Res; 2007 Sep; 56(3):209-16. PubMed ID: 17651983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats.
    Keegan A; Jack AM; Cotter MA; Cameron NE
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):606-13. PubMed ID: 10774792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diabetes and evening primrose oil treatment on responses of aorta, corpus cavernosum and mesenteric vasculature in rats.
    Jack AM; Keegan A; Cotter MA; Cameron NE
    Life Sci; 2002 Sep; 71(16):1863-77. PubMed ID: 12175702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.
    Paskaloglu K; Sener G; Ayanğolu-Dülger G
    Eur J Pharmacol; 2004 Sep; 499(3):345-54. PubMed ID: 15381057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice.
    da Silva FH; Pereira MN; Franco-Penteado CF; De Nucci G; Antunes E; Claudino MA
    Int J Impot Res; 2013; 25(2):69-73. PubMed ID: 23034509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins ameliorate glomerular permeability changes in streptozotocin-induced diabetic rats.
    Mooradian AD; Haas MJ
    Am J Ther; 2007; 14(1):41-5. PubMed ID: 17303974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
    Landsberger M; Jantzen F; Könemann S; Felix SB
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
    Wingard CJ; Moukdar F; Prasad RY; Cathey BL; Wilkinson L
    J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):269-78. PubMed ID: 19267849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.
    Otto A; Fontaine J; Tschirhart E; Fontaine D; Berkenboom G
    Br J Pharmacol; 2006 Jun; 148(4):544-52. PubMed ID: 16633368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.
    Tian XY; Wong WT; Xu A; Chen ZY; Lu Y; Liu LM; Lee VW; Lau CW; Yao X; Huang Y
    Br J Pharmacol; 2011 Sep; 164(2b):598-606. PubMed ID: 21486274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.
    Pelat M; Dessy C; Massion P; Desager JP; Feron O; Balligand JL
    Circulation; 2003 May; 107(19):2480-6. PubMed ID: 12719275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle.
    Kim N; Azadzoi KM; Goldstein I; Saenz de Tejada I
    J Clin Invest; 1991 Jul; 88(1):112-8. PubMed ID: 1647413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
    Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
    Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition.
    Nangle MR; Cotter MA; Cameron NE
    Int J Impot Res; 2006; 18(3):258-63. PubMed ID: 16355109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice.
    Nangle MR; Cotter MA; Cameron NE
    Pflugers Arch; 2004 May; 448(2):139-45. PubMed ID: 14722775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.